MaxCyte, Inc. logo MXCT - MaxCyte, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 4
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $6.00 DETAILS
HIGH: $6.00
LOW: $6.00
MEDIAN: $6.00
CONSENSUS: $6.00
UPSIDE: 476.92%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue 33.0 38.6 41.3 44.3 33.9 26.2 21.6 16.7 14.0 12.3 9.3 7.2 6.8 5.1
Cost of Revenue 6.2 7.1 4.7 5.1 3.6 2.8 2.5 1.8 1.5 1.3 1.0 1.0 0.8 0.8
Gross Profit 26.8 31.5 36.5 39.2 30.2 23.4 19.1 14.8 12.5 11.0 8.3 6.2 6.0 4.2
Operating Expenses
R&D Expenses 20.8 22.2 23.8 19.5 15.4 17.7 17.6 11.2 11.3 4.7 3.0 2.5 2.2 2.2
SG&A Expenses 47.0 56.4 57.0 44.5 31.7 15.7 13.4 12.0 10.5 9.0 6.0 5.0 4.6 4.0
Other Expenses 4.2 4.1 4.0 2.5 1.3 1.0 0.5 0 0 0.0 0.0 0 0 0
Operating Expenses 72.1 82.7 84.8 66.5 48.4 34.5 31.5 23.3 21.8 13.7 9.0 7.5 6.8 6.2
Operating Income
Operating Income (45.3) (51.2) (48.3) (27.4) (18.2) (11.1) (12.4) (8.4) (9.3) (2.7) (0.8) (1.3) (0.8) (2.0)
Interest Expense 0 0 0 0.1 1.0 0.8 0.7 0.6 0.6 0.6 0.7 0.6 0.2 0.1
Interest Income 7.3 10.1 10.4 3.9 0.2 0.1 0.2 0.2 0 0 0 0 0 0.0
Profitability
EBITDA (40.1) (46.4) (44.1) (24.7) (16.6) (9.9) (11.6) (7.9) (9.1) (2.6) (0.6) (1.2) (0.7) (1.8)
EBIT (45.3) (51.2) (48.3) (27.4) (18.0) (11.0) (12.2) (8.3) (9.3) (2.7) (0.7) (1.3) (0.8) (1.9)
Income Before Tax (44.6) (41.1) (37.9) (23.6) (19.1) (11.8) (12.9) (8.9) (9.9) (3.3) (1.4) (1.8) (1.0) (2.0)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (44.6) (41.1) (37.9) (23.6) (19.1) (11.8) (12.9) (8.9) (9.9) (3.3) (1.4) (1.8) (1.0) (2.0)
Per Share Data
EPS (Basic) -0.42 -0.39 -0.37 -0.19 -0.22 -0.18 -0.24 -0.17 -0.20 -0.10 -0.03 -1.59 -0.02 -0.05
EPS (Diluted) -0.42 -0.39 -0.37 -0.19 -0.22 -0.18 -0.24 -0.17 -0.20 -0.10 -0.03 -1.59 -0.02 -0.05
Shares Outstanding 106.4 104.8 103.3 101.7 90.6 69.5 56.4 51.2 48.6 33.5 43.5 1.2 43.5 43.5
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 20.1 27.9 46.5 11.1 47.8 18.8 15.2 11.2 25.3 11.7
Short-Term Investments 83.0 126.6 121.8 216.3 207.3 16.0 1.5 3.2 0 0
Net Receivables 3.5 4.7 5.8 11.2 6.9 5.2 3.2 4.9 3.2 2.4
Inventory 7.5 8.9 12.2 8.6 5.2 4.3 3.7 2.2 1.3 1.3
Other Current Assets 4.3 3.6 3.9 1.9 0 0 0.8 0.9 0.7 0.3
Total Current Assets 118.4 171.7 190.2 252.3 270.4 45.3 24.5 22.4 30.6 15.8
Non-Current Assets
Property, Plant & Equipment 28.5 30.5 34.8 33.6 13.4 6.5 5.5 1.8 0.8 0.3
Goodwill 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0.7 0 0 0 0 0 0 0 0 0
Long-Term Investments 52.6 35.8 42.9 0 0 0 0 0 0 0
Other Non-Current Assets 2.5 1.5 0.4 0.8 0.3 0.0 0 0 0 0
Total Non-Current Assets 84.1 67.8 78.1 34.4 13.7 6.5 5.5 1.8 0.8 0.3
Total Assets 202.5 239.5 268.3 286.7 284.1 51.8 30.0 24.3 31.4 16.1
Current Liabilities
Account Payables 1.4 1.4 0.7 0.3 1.8 0.9 2.1 1.0 4.3 3.2
Short-Term Debt 1.5 0.9 0 0 0 0 0 0 0.9 0
Deferred Revenue 3.6 5.3 5.1 0 6.7 4.8 3.2 2.4 2.1 2.5
Other Current Liabilities 7.8 8.3 0 6.7 0 0 0 0 (0.9) 0
Total Current Liabilities 14.3 15.8 17.9 15.4 15.6 11.6 9.3 6.6 7.2 5.7
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 4.9 4.9 5.1 4.2 5.0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0.3 0.3 0.3 1.3 0.5 0.6 0.3 0.4 0.4 0.3
Total Non-Current Liabilities 16.8 17.4 18.3 17.3 5.6 6.9 7.0 5.4 4.6 5.3
Total Liabilities 31.0 33.2 36.1 32.7 21.2 18.6 16.4 12.0 11.8 11.0
Stockholders' Equity
Common Stock 1.1 1.1 1.0 1.0 1.0 0.8 0.6 0.5 0.5 0.4
Retained Earnings (261.5) (216.9) (175.8) (137.9) (114.3) (95.2) (83.4) (70.5) (61.6) (51.7)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 171.5 206.3 232.2 254.0 262.9 33.2 13.6 12.3 19.6 5.1
Total Liabilities & Equity 202.5 239.5 268.3 286.7 284.1 51.8 30.0 24.3 31.4 16.1
Debt Metrics
Total Debt 17.9 18.0 18.7 16.1 5.7 7.0 7.2 5.1 5.0 5.0
Net Debt (2.1) (9.8) (27.8) 5.0 (42.1) (11.8) (8.0) (6.2) (20.3) (6.7)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Operating Activities
Net Income (44.6) (41.1) (37.9) (23.6) (19.1) (11.8) (12.9) (8.9) (9.9) (3.3)
Depreciation & Amortization 5.1 4.3 4.6 2.7 1.4 1.0 0.6 0.3 0.1 0.1
Stock-Based Compensation 9.2 0 14.0 0 8.0 2.5 1.8 1.3 0.5 0.2
Change in Working Capital (6.1) (0.8) 3.8 (3.2) (1.6) (0.9) 1.6 (3.5) (0.5) 0.7
Other Non-Cash Items 2.0 9.9 (6.1) 9.3 0.7 0.4 0.1 0.1 0.1 0.1
Operating Cash Flow (34.4) (27.6) (21.7) (14.8) (10.7) (8.8) (8.8) (10.5) (9.7) (2.3)
Investing Activities
Capital Expenditure (1.8) (1.7) (3.7) (18.5) (3.8) (2.1) (1.3) (0.7) (0.6) (0.2)
Acquisitions (1.8) 0 0 0 0 0 (1.7) 0 0 0
Purchases of Investments (126.3) (150.9) (255.1) (290.9) (268.7) (22.5) (7.4) (12.7) 0 0
Sales/Maturities of Investments 155.8 159.4 313.8 284.6 77.5 8 9.1 9.6 0 0
Other Investing Activities 0 0 0.0 0 0.0 0 1.7 (3.1) 0 0
Investing Cash Flow 25.9 6.9 55.0 (24.8) (195.0) (16.6) 0.5 (3.8) (0.6) (0.2)
Financing Activities
Net Debt Issuance 0 0 0 0 (5.0) (0.1) (0.2) (0.0) (0.0) (0.0)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 1.9 0 3.6 0.4 0.1 0.2 0.0 (0.1)
Financing Cash Flow 0.7 2.1 2.1 2.9 234.7 28.9 12.3 0.2 23.9 11.9
Cash Position
Net Change in Cash (7.8) (18.6) 35.4 (36.7) 29.0 3.5 4.0 (14.1) 13.6 9.3
Cash at Beginning 27.9 46.5 11.1 47.8 18.8 15.2 11.2 25.3 11.7 2.4
Cash at End 20.1 27.9 46.5 11.1 47.8 18.8 15.2 11.2 25.3 11.7
Free Cash Flow (36.2) (29.3) (25.4) (33.3) (14.5) (10.9) (10.1) (11.2) (10.3) (2.6)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Income Statement
Revenue 33.0 38.6 41.3 44.3 33.9 26.2 21.6 16.7 14.0 12.3 9.3 7.2 6.8 5.1
Gross Profit 26.8 31.5 36.5 39.2 30.2 23.4 19.1 14.8 12.5 11.0 8.3 6.2 6.0 4.2
Operating Income (45.3) (51.2) (48.3) (27.4) (18.2) (11.1) (12.4) (8.4) (9.3) (2.7) (0.8) (1.3) (0.8) (2.0)
Net Income (44.6) (41.1) (37.9) (23.6) (19.1) (11.8) (12.9) (8.9) (9.9) (3.3) (1.4) (1.8) (1.0) (2.0)
EPS (Diluted) -0.42 -0.39 -0.37 -0.19 -0.22 -0.18 -0.24 -0.17 -0.20 -0.10 -0.03 -1.59 -0.02 -0.05
Balance Sheet
Cash & Equivalents 20.1 27.9 46.5 11.1 47.8 18.8 15.2 11.2 25.3 11.7
Total Assets 202.5 239.5 268.3 286.7 284.1 51.8 30.0 24.3 31.4 16.1
Total Debt 17.9 18.0 18.7 16.1 5.7 7.0 7.2 5.1 5.0 5.0
Stockholders' Equity 171.5 206.3 232.2 254.0 262.9 33.2 13.6 12.3 19.6 5.1
Cash Flow
Operating Cash Flow (34.4) (27.6) (21.7) (14.8) (10.7) (8.8) (8.8) (10.5) (9.7) (2.3)
Capital Expenditure (1.8) (1.7) (3.7) (18.5) (3.8) (2.1) (1.3) (0.7) (0.6) (0.2)
Free Cash Flow (36.2) (29.3) (25.4) (33.3) (14.5) (10.9) (10.1) (11.2) (10.3) (2.6)